Stockholders' Equity (Tables)

12 Months Ended

Jun. 30, 2025

Stockholders' Equity Note [Abstract]

Schedule of Activity of Restricted Stock Units

The following table summarizes the activity of RSUs and PRSUs during year ended June 30, 2025 (in thousands, except years and per share amounts):


			Weighted Average Grant-Date Fair Value				Weighted Average Remaining Contractual Term in Years
	Restricted Stock Units	Performance Restricted Stock Units	Restricted Stock Units		Performance Restricted Stock Units		Restricted Stock Units	Performance Restricted Stock Units
Outstanding at beginning of period	791	348	$	175.09	$	204.02	1.6	1.7
Granted	371	79	240.69		241.73
Vested*	(247)	(53)	183.95		193.24

Forfeited	(82)	(32)	181.27		187.33
Outstanding at end of period	833	342	$	201.05	$	213.28	1.5	1.5

*Includes 53 thousand RSUs and 20 thousand PRSUs netted for tax.

Schedule of Option Activity

The following table summarizes option activity during the year ended June 30, 2025 (in thousands, except years and per share amounts):


	Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period	786	$	146.90	2.8
Granted	35	249.56
Exercised	(293)	105.35
Forfeited	(11)	222.57
Outstanding at end of period	517	$	175.61	2.7
Options exercisable at end of period	415	$	169.87	2.0
Options vested and expected to vest at end of period	512	$	175.35	2.7

Schedule of Assumptions for Fair Value of Stock Option Plans and Purchase Rights Granted


	2025	2024	2023
Performance restricted stock units
Weighted average grant date fair value	$272.47	$168.14	$208.40
Weighted average risk-free interest rate	4.23%	4.50%	3.75%
Expected life in years	3 - 4	3 - 4	4
Dividend yield(1)	0.88%	1.29%	0.78% - 0.84%
Expected volatility	32% - 34%	31% - 36%	32%
Average peer volatility(2)	31%	31%	—
Average peer correlation coefficient(3)	0.5189	0.5385	—

Stock options:
Weighted average grant date fair value	$88.54	$50.48	$74.95
Weighted average risk-free interest rate	4.17%	4.44%	3.85%
Expected life in years	4.9	4.9	4.9
Dividend yield	0.85%	1.29%	0.78%
Expected volatility	37%	36%	34%

ESPP purchase rights:
Weighted average grant date fair value	$59.55	$47.40	$52.38
Weighted average risk-free interest rate	4.7%	5.4%	3.6%
Expected life in years	0.5	0.5	0.5
Dividend yield	0.87% - 0.90%	0.75% - 1.30%	0.75% - 0.84%
Expected volatility	34% - 39%	27% - 40%	27% - 34%

(1) The dividend yield used to project the value of the stock delivered to the holder is based on historical dividends and the expectation of future dividend payouts. Total stockholder return is determined assuming the reinvestment of dividends over the performance period, which is mathematically equivalent to a 0% dividend yield.

(2) The correlation coefficients are based upon the stock price data used to estimate the volatility assumptions.

(3) The average peer volatility is estimated based upon the historical volatility of each peer company.

Schedule of Total Stock-Based Compensation Costs Incurred and Associated Tax Benefit Recognized

The following table summarizes total stock-based compensation costs incurred and the associated tax benefit recognized during the years ended June 30, 2025, 2024 and 2023 (in thousands):


	2025		2024		2023
Cost of sales	$	8,945	$	7,563	$	6,465
Selling, general and administrative expenses	64,588		58,149		53,049
Research and development expenses	18,128		14,472		11,628
Stock-based compensation costs	91,661		80,184		71,142
Tax benefit	(21,833)		(15,053)		(24,860)
Stock-based compensation costs, net of tax benefit	$	69,828	$	65,131	$	46,282